CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 217.7	$ 342.4
Short-term investments	222.6	157.9
Accounts receivable, net	240.4	243.9
Inventories	505.1	440.4
Other current assets	113.8	91.3
Total current assets	1,299.6	1,275.9
Property, plant and equipment, net	252.8	239.1
Goodwill	165.4	130.6
Intangibles, net and other long-term assets	195.1	162.8
Total assets	1,912.9	1,808.4
Current liabilities:
Current portion of long-term debt	0.1	20.1
Accounts payable	91.7	86.1
Customer advances	136.4	149.0
Other current liabilities	265.4	269.5
Total current liabilities	493.6	524.7
Long-term debt	430.7	391.6
Other long-term liabilities	225.5	199.0
Commitments and contingencies (Note 11)
Shareholders' equity:
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value 260,000,000 shares authorized, 171,158,642 and 170,552,890 shares issued and 158,858,855 and 159,854,695 shares outstanding at June 30, 2017 and December 31, 2016, respectively	1.7	1.7
Treasury stock, at cost, 12,299,787 and 10,698,195 shares at June 30, 2017 and December 31, 2016, respectively	(293.3)	(249.3)
Accumulated other comprehensive loss	(13.0)	(75.9)
Other shareholders' equity	1,060.3	1,009.9
Total shareholders' equity attributable to Bruker Corporation	755.7	686.4
Noncontrolling interest in consolidated subsidiaries	7.4	6.7
Total shareholders' equity	763.1	693.1
Total liabilities and shareholders' equity	$ 1,912.9	$ 1,808.4